search
Back to results

A Smartphone-Assisted Brief Behavioral Intervention for Pregnant Women With Depression

Primary Purpose

Perinatal Depression

Status
Completed
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Motherly 1.0
Brief Psychotherapy
Educational app
Sponsored by
University of Sao Paulo
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Perinatal Depression

Eligibility Criteria

16 Years - 40 Years (Child, Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • women aged between 16-40 years;
  • having a score of >7 on the Edinburgh Postnatal Depression Scale (EPDS);
  • gestational age between 17-26 weeks;
  • being literate;
  • owning a functional smartphone with Android for personal use.

Exclusion Criteria:

  • pregnancies classified as being at risk, fetal malformation, or congenital disease;
  • visual, auditory or intellectual disabilities, or chronic diseases associated with fetal development alterations;
  • severe and/or chronic mental disorder (e.g., schizophrenia, bipolar disorder, etc).

Sites / Locations

  • Daniel Fatori

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Motherly app with brief psychotherapy

Educational app (Active control)

Arm Description

Participants in this arm will receive intervention via Motherly 1.0, an app that delivers behavioral activation strategies and psychoeducational content to promote changes in sleep, nutrition, and physical activity habits. It has also functionalities that help participants to engage in prenatal care, breastfeeding, and social support, and to stimulate child development. In addition will undergo brief Cognitive-Behavioral Therapy (CBT) with a focus on behavioral activation.

Participants in this arm will have access to a psychoeducational app (active control) which delivers content about gestation, maternal health and mental health, and child development. In addition, they will undergo will undergo brief Cognitive-Behavioral Therapy (CBT) with a focus on behavioral activation.

Outcomes

Primary Outcome Measures

Change in Maternal Prenatal Depression at Baseline, Midpoint, and Posttreatment (8 Weeks)
Participants were assessed with the Edinburgh Postnatal Depression Scale (EPDS) at baseline, at 4 weeks, and at 8 weeks (posttreatment). (EPDS max-min scores=0-30, higher scores=worse outcome).

Secondary Outcome Measures

Change in Maternal Prenatal Anxiety From Baseline to Posttreatment (8 Weeks)
Participants will be assessed with the Generalized Anxiety Disorder 7 (GAD-7) at baseline, at 4 weeks, and at 8 weeks (posttreatment). (GAD-7 max-min scores=0-21, higher scores=worse outcome).
Change in Maternal Prenatal Quality of Life From Baseline to Posttreatment (8 Weeks)
Participants will be assessed with the 12-item health survey (SF-12) at baseline, at 4 weeks, and at 8 weeks (posttreatment). (SF-12 max-min scores=12-50, higher scores=worse outcome).
Change in Maternal Prenatal Psychological Well-Being From Baseline to Posttreatment (8 Weeks).
Participants were assessed with the Ryff's Psychological Well-Being Scale at baseline and at 8 weeks (posttreatment). (Ryff's Psychological Well-Being Scale max-min Total scores=36-216; higher scores=better outcome).
Change in Maternal Physical Activity Levels From Baseline to Posttreatment (8 Weeks).
Participants were assessed with the International Physical Activity Questionnaire (IPAQ) at baseline and at 8 weeks (posttreatment). (IPAQ measures Total Metabolic Equivalent of Task (MET) minutes per week (MET-min per week), higher MET-min per week=better outcome).
Change in Maternal Prenatal Perceived Stress From Baseline to Posttreatment (8 Weeks).
Participants were assessed with the Perceived Stress Scale (PSS) at baseline, at 4 weeks, and at 8 weeks (posttreatment). (PSS max-min scores=0-40, higher scores=worse outcome).
Change in Maternal Prenatal Depression Severity From Baseline to Posttreatment (8 Weeks).
Participants were assessed with the Clinical Global Impressions Scale-Improvement (CGI-I). (scores in this scale are: 1=very much improved, 2= much improved, 3= minimally improved, 4 = no change, 5 = minimally worse, 6= much worse, 7= very much worse; scores were recoded as binary variable: improved (1, 2, 3) vs not-improved (4, 5, 6, 7).
Change in Maternal Prenatal Sleep Quality From Baseline to Posttreatment (8 Weeks).
Participants were assessed with the Single-item Sleep Quality Scale (SIMP) at baseline, at 4 weeks, and at 8 weeks (posttreatment). (SIMP max-min scores=0-10, higher scores=better outcome).
Infant Developmental Milestones at 2 Months of Age.
Child developmental milestones will be assessed with the Survey of Well-being of Young Children (SWYC) at 2 months of the child's age. (SWYC min-max=0-20, higher scores=better outcome).
Infant Social/Emotional Problems at 2 Months of Age.
Infants will be assessed with the Baby Pediatric Symptom Checklist (BPSC) at 2 months of the child's age. (BPSC min-max=0-24, higher scores=worse outcome).
Change in Maternal Prenatal Depression From Baseline to Follow-up.
Participants will be assessed with the Edinburgh Postnatal Depression Scale (EPDS) at baseline and when the infant is two months of age (Follow-up, T3). (EPDS max-min scores=0-30, higher scores=worse outcome).
Change in Maternal Prenatal Anxiety From Baseline to to Follow-up.
Participants will be assessed with the Generalized Anxiety Disorder 7 (GAD-7) at baseline and when the infant is two months of age (Follow-up, T3). (GAD-7 max-min scores=0-21, higher scores=worse outcome).
Change in Maternal Prenatal Quality of Life From Baseline to to Follow-up.
Participants will be assessed with the 12-item health survey (SF-12) at baseline and when the infant is two months of age (Follow-up, T3). (SF-12 max-min scores=12-50, higher scores=worse outcome).
Change in Maternal Prenatal Psychological Well-Being From Baseline to Follow-up.
Participants will be assessed with the Ryff's Psychological Well-Being Scale at baseline and when the infant is two months of age (Follow-up, T3). (Ryff's Psychological Well-Being Scale max-min scores=6-36, higher scores=better outcome).
Change in Maternal Prenatal Perceived Stress From Baseline to Follow-up.
Participants will be assessed with the Perceived Stress Scale (PSS) at baseline and when the infant is two months of age (Follow-up, T3). (PSS max-min scores=0-40, higher scores=worse outcome).
Change in Maternal Prenatal Depression Severity From Baseline to Follow-up.
Participants will be assessed with the Clinical Global Impressions Scale-Improvement (CGI-I) when the infant is two months of age (Follow-up, T3). (CGI-I, min-max=0-7, higher scores=worst outcome).
Change in Maternal Prenatal Sleep Quality From Baseline to Follow-up.
Participants will be assessed with the Single-item Sleep Quality Scale (SIMP) at baseline and when the infant is two months of age (Follow-up, T3). (SIMP max-min scores=0-10, higher scores=better outcome).

Full Information

First Posted
July 23, 2020
Last Updated
November 10, 2021
Sponsor
University of Sao Paulo
Collaborators
Grand Challenges Canada, Fundação Maria Cecilia Souto Vidigal
search

1. Study Identification

Unique Protocol Identification Number
NCT04495166
Brief Title
A Smartphone-Assisted Brief Behavioral Intervention for Pregnant Women With Depression
Official Title
Smartphone-Assisted Brief Behavioral Intervention for Pregnant Women With Depression
Study Type
Interventional

2. Study Status

Record Verification Date
November 2021
Overall Recruitment Status
Completed
Study Start Date
August 3, 2020 (Actual)
Primary Completion Date
November 23, 2020 (Actual)
Study Completion Date
April 27, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Sao Paulo
Collaborators
Grand Challenges Canada, Fundação Maria Cecilia Souto Vidigal

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Investigators developed Motherly 1.0, a smartphone app designed to treat and promote maternal mental health. A 2-arm parallel-randomized controlled clinical trial (RCT) will be conducted to test the efficacy of Motherly in conjunction with brief cognitive-behavioral therapy. 70 pregnant women between 16-40 years old will be recruited. Since all interventions will be conducted online, participants will be recruited from any Brazilian state or municipality. Participants will be randomly assigned to either receive intervention via app consisting of behavioral activation and psychoeducation to promote changes in sleep, nutrition, and physical activity habits, as well as to engage in prenatal care, breastfeeding, and social support, and to stimulate child development, in addition to brief cognitive-behavioral therapy (CBT) (n=35); or to a comparison group receiving an psychoeducational app (active control) with psychoeducational content about gestation, maternal health and mental health, and child development in addition to brief CBT (n=35). Duration of treatment will be eight weeks, during which participants in both groups will be assessed at the beginning (baseline; T0), weeks 3-4 (midpoint; T1), and week 8 (endpoint; T2) in order to evaluate treatment effects. A follow-up postnatal assessment will also be conducted when the child is three months of age (T3).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Perinatal Depression

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
81 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Motherly app with brief psychotherapy
Arm Type
Experimental
Arm Description
Participants in this arm will receive intervention via Motherly 1.0, an app that delivers behavioral activation strategies and psychoeducational content to promote changes in sleep, nutrition, and physical activity habits. It has also functionalities that help participants to engage in prenatal care, breastfeeding, and social support, and to stimulate child development. In addition will undergo brief Cognitive-Behavioral Therapy (CBT) with a focus on behavioral activation.
Arm Title
Educational app (Active control)
Arm Type
Active Comparator
Arm Description
Participants in this arm will have access to a psychoeducational app (active control) which delivers content about gestation, maternal health and mental health, and child development. In addition, they will undergo will undergo brief Cognitive-Behavioral Therapy (CBT) with a focus on behavioral activation.
Intervention Type
Behavioral
Intervention Name(s)
Motherly 1.0
Intervention Description
A mobile app designed to promote life habits that have been shown to improve physical and mental health in pregnant women. The app consists of a package of specific and customized interventions defined by eight different modules: 1) Mental Health; 2) Sleep; 3) Nutrition; 4) Physical activity; 5) Social support; 6) Prenatal support; 7) Postnatal support, and 8) Library of pre and postnatal content. The app relies on extensive psychoeducational content delivered as tutorials, brief messages, and available as a library that can be read at the users' discretion; behavior monitoring using schedules, checklists, and notifications to help participants keep track of their health care visits, and schedule behavior activation activities; and gaming elements such as changes in background appearance to reflect participant's mood assessment and ratings of activities, and graphical and easy-to-use questionnaires for obtaining information (mood, nutrition habits).
Intervention Type
Behavioral
Intervention Name(s)
Brief Psychotherapy
Intervention Description
Brief Cognitive-Behavioral Therapy (CBT) with a focus on behavioral activation (BA). Participants will be guided by psychotherapists to plan, schedule, and engage in positively reinforcing activities, and will be aided to develop problem-solving strategies for circumventing barriers to completing scheduled activities. Implementation of these techniques will be conducted with the aid of the Motherly 1.0 for participants in the experimental arm; for participants in the control arm, BA will be implemented without the aid of Motherly 1.0. Throughout the four sessions, psychotherapists will monitor participants' adherence, answering questions about the strategies and providing support for solving problems or CBT techniques, such as cognitive restructuring, relaxation techniques, sleep hygiene, stress and anxiety management, among other evidence-based techniques might be used if appropriate to the case.
Intervention Type
Behavioral
Intervention Name(s)
Educational app
Intervention Description
A simplified version of the Motherly 1.0 app consisting of psychoeducational content about various aspects of pregnancy, maternal physical and mental health, and child development. Active intervention functionalities, such as behavioral activation, activity scheduling, sleep hygiene, among others, are NOT present in this simplified version of the app.
Primary Outcome Measure Information:
Title
Change in Maternal Prenatal Depression at Baseline, Midpoint, and Posttreatment (8 Weeks)
Description
Participants were assessed with the Edinburgh Postnatal Depression Scale (EPDS) at baseline, at 4 weeks, and at 8 weeks (posttreatment). (EPDS max-min scores=0-30, higher scores=worse outcome).
Time Frame
Baseline (T0), Weeks 3-4 (Midpoint, T1), Week 8 (Posttreatment, T2).
Secondary Outcome Measure Information:
Title
Change in Maternal Prenatal Anxiety From Baseline to Posttreatment (8 Weeks)
Description
Participants will be assessed with the Generalized Anxiety Disorder 7 (GAD-7) at baseline, at 4 weeks, and at 8 weeks (posttreatment). (GAD-7 max-min scores=0-21, higher scores=worse outcome).
Time Frame
Baseline (T0), Weeks 3-4 (Midpoint, T1), Week 8 (Posttreatment, T2).
Title
Change in Maternal Prenatal Quality of Life From Baseline to Posttreatment (8 Weeks)
Description
Participants will be assessed with the 12-item health survey (SF-12) at baseline, at 4 weeks, and at 8 weeks (posttreatment). (SF-12 max-min scores=12-50, higher scores=worse outcome).
Time Frame
Baseline (T0), Weeks 3-4 (Midpoint, T1), Week 8 (Posttreatment, T2).
Title
Change in Maternal Prenatal Psychological Well-Being From Baseline to Posttreatment (8 Weeks).
Description
Participants were assessed with the Ryff's Psychological Well-Being Scale at baseline and at 8 weeks (posttreatment). (Ryff's Psychological Well-Being Scale max-min Total scores=36-216; higher scores=better outcome).
Time Frame
Baseline (T0), Week 8 (Posttreatment, T2).
Title
Change in Maternal Physical Activity Levels From Baseline to Posttreatment (8 Weeks).
Description
Participants were assessed with the International Physical Activity Questionnaire (IPAQ) at baseline and at 8 weeks (posttreatment). (IPAQ measures Total Metabolic Equivalent of Task (MET) minutes per week (MET-min per week), higher MET-min per week=better outcome).
Time Frame
Baseline (T0), Week 8 (Posttreatment, T2).
Title
Change in Maternal Prenatal Perceived Stress From Baseline to Posttreatment (8 Weeks).
Description
Participants were assessed with the Perceived Stress Scale (PSS) at baseline, at 4 weeks, and at 8 weeks (posttreatment). (PSS max-min scores=0-40, higher scores=worse outcome).
Time Frame
Baseline (T0), Weeks 3-4 (Midpoint, T1), Week 8 (Posttreatment, T2).
Title
Change in Maternal Prenatal Depression Severity From Baseline to Posttreatment (8 Weeks).
Description
Participants were assessed with the Clinical Global Impressions Scale-Improvement (CGI-I). (scores in this scale are: 1=very much improved, 2= much improved, 3= minimally improved, 4 = no change, 5 = minimally worse, 6= much worse, 7= very much worse; scores were recoded as binary variable: improved (1, 2, 3) vs not-improved (4, 5, 6, 7).
Time Frame
Weeks 3-4 (Midpoint, T1), Week 8 (Posttreatment, T2).
Title
Change in Maternal Prenatal Sleep Quality From Baseline to Posttreatment (8 Weeks).
Description
Participants were assessed with the Single-item Sleep Quality Scale (SIMP) at baseline, at 4 weeks, and at 8 weeks (posttreatment). (SIMP max-min scores=0-10, higher scores=better outcome).
Time Frame
Baseline (T0), Weeks 3-4 (Midpoint, T1), Week 8 (Posttreatment, T2).
Title
Infant Developmental Milestones at 2 Months of Age.
Description
Child developmental milestones will be assessed with the Survey of Well-being of Young Children (SWYC) at 2 months of the child's age. (SWYC min-max=0-20, higher scores=better outcome).
Time Frame
When the infant is two months of age (Follow-up, T3).
Title
Infant Social/Emotional Problems at 2 Months of Age.
Description
Infants will be assessed with the Baby Pediatric Symptom Checklist (BPSC) at 2 months of the child's age. (BPSC min-max=0-24, higher scores=worse outcome).
Time Frame
When the infant is two months of age (Follow-up, T3).
Title
Change in Maternal Prenatal Depression From Baseline to Follow-up.
Description
Participants will be assessed with the Edinburgh Postnatal Depression Scale (EPDS) at baseline and when the infant is two months of age (Follow-up, T3). (EPDS max-min scores=0-30, higher scores=worse outcome).
Time Frame
Baseline (T0), when the infant is two months of age (Follow-up, T3).
Title
Change in Maternal Prenatal Anxiety From Baseline to to Follow-up.
Description
Participants will be assessed with the Generalized Anxiety Disorder 7 (GAD-7) at baseline and when the infant is two months of age (Follow-up, T3). (GAD-7 max-min scores=0-21, higher scores=worse outcome).
Time Frame
Baseline (T0), when the infant is two months of age (Follow-up, T3).
Title
Change in Maternal Prenatal Quality of Life From Baseline to to Follow-up.
Description
Participants will be assessed with the 12-item health survey (SF-12) at baseline and when the infant is two months of age (Follow-up, T3). (SF-12 max-min scores=12-50, higher scores=worse outcome).
Time Frame
Baseline (T0), when the infant is two months of age (Follow-up, T3).
Title
Change in Maternal Prenatal Psychological Well-Being From Baseline to Follow-up.
Description
Participants will be assessed with the Ryff's Psychological Well-Being Scale at baseline and when the infant is two months of age (Follow-up, T3). (Ryff's Psychological Well-Being Scale max-min scores=6-36, higher scores=better outcome).
Time Frame
Baseline (T0), when the infant is two months of age (Follow-up, T3).
Title
Change in Maternal Prenatal Perceived Stress From Baseline to Follow-up.
Description
Participants will be assessed with the Perceived Stress Scale (PSS) at baseline and when the infant is two months of age (Follow-up, T3). (PSS max-min scores=0-40, higher scores=worse outcome).
Time Frame
Baseline (T0), when the infant is two months of age (Follow-up, T3).
Title
Change in Maternal Prenatal Depression Severity From Baseline to Follow-up.
Description
Participants will be assessed with the Clinical Global Impressions Scale-Improvement (CGI-I) when the infant is two months of age (Follow-up, T3). (CGI-I, min-max=0-7, higher scores=worst outcome).
Time Frame
Baseline (T0), when the infant is two months of age (Follow-up, T3).
Title
Change in Maternal Prenatal Sleep Quality From Baseline to Follow-up.
Description
Participants will be assessed with the Single-item Sleep Quality Scale (SIMP) at baseline and when the infant is two months of age (Follow-up, T3). (SIMP max-min scores=0-10, higher scores=better outcome).
Time Frame
Baseline (T0), when the infant is two months of age (Follow-up, T3).

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: women aged between 16-40 years; having a score of >7 on the Edinburgh Postnatal Depression Scale (EPDS); gestational age between 17-26 weeks; being literate; owning a functional smartphone with Android for personal use. Exclusion Criteria: pregnancies classified as being at risk, fetal malformation, or congenital disease; visual, auditory or intellectual disabilities, or chronic diseases associated with fetal development alterations; severe and/or chronic mental disorder (e.g., schizophrenia, bipolar disorder, etc).
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Daniel Fatori, PhD
Organizational Affiliation
Medical School, University of Sao Paulo
Official's Role
Principal Investigator
Facility Information:
Facility Name
Daniel Fatori
City
São Paulo
Country
Brazil

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
21545782
Citation
Sockol LE, Epperson CN, Barber JP. A meta-analysis of treatments for perinatal depression. Clin Psychol Rev. 2011 Jul;31(5):839-49. doi: 10.1016/j.cpr.2011.03.009. Epub 2011 Mar 27.
Results Reference
background
PubMed Identifier
17549635
Citation
Graham JW, Olchowski AE, Gilreath TD. How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev Sci. 2007 Sep;8(3):206-13. doi: 10.1007/s11121-007-0070-9. Epub 2007 Jun 5.
Results Reference
background
PubMed Identifier
33757591
Citation
Zuccolo PF, Xavier MO, Matijasevich A, Polanczyk G, Fatori D. A smartphone-assisted brief online cognitive-behavioral intervention for pregnant women with depression: a study protocol of a randomized controlled trial. Trials. 2021 Mar 23;22(1):227. doi: 10.1186/s13063-021-05179-8.
Results Reference
derived

Learn more about this trial

A Smartphone-Assisted Brief Behavioral Intervention for Pregnant Women With Depression

We'll reach out to this number within 24 hrs